Selective CDK7 Inhibition Has Dual Activity in Treatment Resistant Estrogen Receptor Positive Breast Cancer

Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Héraud, Mathew Joseph Leventhal, Avery Feit, Gabriella Cohen Feit, Ariel Feiglin, Weihan Liu, Francisco Hermida‐Prado, Nikolas Kesten, Wen Ma, Carmine De Angelis, Antonio Morlando, Madison O'Donnell, Sergey Naumenko, Shixia Huang, Quang‐Dé Nguyen, Ying Huang, Luca Malorni, Johann S. Bergholz, Jean J. Zhao, Ernest Fraenkel, Rachel Schiff, Geoffrey I. Shapiro, Rinath JeselsohnSSRN 2023 · DOI

BibTeX
@misc{guarducci2023selective,
  author = {Cristina Guarducci and Agostina Nardone and Douglas Russo and Zsuzsanna Nagy and Capucine Héraud and Mathew Joseph Leventhal and Avery Feit and Gabriella Cohen Feit and Ariel Feiglin and Weihan Liu and Francisco Hermida‐Prado and Nikolas Kesten and Wen Ma and Carmine De Angelis and Antonio Morlando and Madison O'Donnell and Sergey Naumenko and Shixia Huang and Quang‐Dé Nguyen and Ying Huang and Luca Malorni and Johann S. Bergholz and Jean J. Zhao and Ernest Fraenkel and Rachel Schiff and Geoffrey I. Shapiro and Rinath Jeselsohn},
  title = {{Selective CDK7 Inhibition Has Dual Activity in Treatment Resistant Estrogen Receptor Positive Breast Cancer}},
  year = {2023},
  doi = {10.2139/ssrn.4423990},
  howpublished = {SSRN},
}

Loading related content...

Figure